Reduction of oxidative stress in amyotrophic lateral sclerosis following pramipexole treatment

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

Volumn 4, Issue 2, 2003, Pages 90-95

  Pattee, Gary L ^a   Post, Gregory R ^b   Gerber, Rebecca E ^c   Bennett Jr , James P ^c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDROXYBENZOIC ACID; ACETYLSALICYLIC ACID; FREE RADICAL; OXYGEN RADICAL; PRAMIPEXOLE; SALICYLIC ACID; SALICYLIC ACID DERIVATIVE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL MODEL; CLINICAL ARTICLE; DISEASE MARKER; DRUG BLOOD LEVEL; DRUG TOLERABILITY; FAMILIAL DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROXYLATION; MITOCHONDRION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0038446768     PISSN: 14660822     EISSN: None     Source Type: Journal    
DOI: 10.1080/14660820310012736     Document Type: Review

References (41)

1. Robberecht W. Oxidative stress in amyotrophic lateral sclerosis. J Neurol 2000; 247 (suppl) 1: 1-6.
2. Cookson MR, Shaw PJ. Oxidative stress and motor neurone disease. Brain Pathol 1999; 9: 165-86.
3. Swerdlow RH, Parks JK, Cassarino DS et al. Mitochondria in sporadic amyotrophic lateral sclerosis. Exp. Neurol 1998; 153: 135-42.
4. Hall ED, Andrus PK, Oostveen JA et al. Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons. Brain Res 1996; 742: 80-88.
5. Anderson DW, Neavin T, Smith JA, Schneider JS. Neuroprotective effects of pramipexole in young and aged MPTP-treated mice. Brain Res 2001; 905: 44-53.
6. Cassarino DS, Fall CP, Smith TS, Bennett JP Jr. Pramipexole reduces reactive oxygen species production in vivo and in vitro and inhibits the mitochondrial permeability transition produced by the Parkinsonian neurotoxin methylpyridinium ion. J. Neurochem 1998; 71: 295-301.
7. Marzo I, Brenner C, Kroemer G. The central role of the mitochondrial megachannel in apoptosis: evidence obtained with intact cells, isolated mitochondria, and purified protein complexes. Biomed Pharmacother 1998; 52: 248-251.
8. Grootveld M, Halliwell B. Aromatic hydroxylation as a potential measure of hydroxyl-radical formation in vivo. Identification of hydroxylated derivatives of salicylate in human body fluids. Biochem J 1986; 15: 499-504.
9. Halliwell B, Kaur H. Hydroxylation of salicylate and phenylalanine as assays for hydroxyl radicals: a cautionary note visited for the third time. Free Rad Res 1997; 27: 239-244.
10. Roth GJ, Stanford N, Majerus PW. Acetylation of prostaglandin synthase by aspirin. Proc Nat Acad Sci USA 1975; 72: 3073-3076.
11. Hertz F, Cloaree A. Pharmacology of free radicals: recent views on their relation to inflammatory mechanisms. Life Sci 1984; 34: 713-720.
12. Kuehl FA, Egan RW. Prostaglandins, arachidonic acid, and inflammation. Science 1980; 210: 978-984.
13. Sielik PH, Marnett LJ. Oxidizing radical generation by prostaglandin H synthase. Methods Enzymol 1984; 105: 412-416.
14. Ferger B, Teismann P, Mierau J. The dopamine agonist pramipexole scavenges hydroxyl free radicals induced by striatal application of 6-hydroxydopamine in rats: an in vivo microdialysis study. Brain Res 2000; 883: 216-23.
15. Kakimura J, Kitamura Y, Takata K et al. Release and aggregation of cytochrome c and alpha-synuclein are inhibited by the anti-Parkinson's drugs, talipexole and pramipexole. Eur J Pharmacol 2001; 417: 59-67.
16. Le WD, Jankovic J, Xie W, Appel SH. Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection. J Neural Transm 2000; 107: 1165-1173.
17. Abramova NA, Cassarino DS, Khan SM et al. Inhibition by R(+) or S(-) pramipexole of activation by methylpyridinium ion or beta amyloid peptide of death pathways in neural cells. J Neurosci Res 2002; 67: 494-500.
18. Bennett JP, Jr, Carvey PM, Hinds TR et al. Mechanisms of action of pramipexole: putative neuroprotective effects. Rev Contemp Pharmacother 2001; 12: 33-58.
19. Pedersen WA, Fu W, Keller JN et al. Protein modification by lipid peroxidation product 4-Hydroxy-nonel in the spinal cords of amyotrophic lateral sclerosis. Ann Neurol 1998; 44: 819-24.
20. Tohgi H, Abe T, Yamazaki K et al. Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis. Ann Neurol 1999; 46: 129-131.
21. Aoyama K, Matsubara K, Fujikawa Y et al. Nitration of manganese superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurode-generative diseases. Ann Neurol 2000; 47: 524-527.
22. Shaw PJ, Eggett CJ. Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis. J Neurol 2000; 247 (suppl) 1: 117-27.
23. Borthwick GM, Johnson MA, Ince PG et al. Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death. Ann Neurol 1999; 46: 787-790.
24. Liu D, Wen J, Liu J, Liping L. The roles of free radicals in amyotrophic lateral sclerosis: reactive oxygen species and elevated oxidation of protein, DNA, and membrane phospholipids. FASEB 1999; 13: 2318-2328.
25. Kruman II, Pedersen WA, Springer JE, Mattson MP. ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp Neurol 1999; 160: 28-39.
26. Martin LJ. Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. J Neuropath Exp Neurol 1999; 58: 459-471.
27. Li M, Ona VO, Guegan C et al. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 2000; 288: 335-339.
28. Wong PC, Pardo CA, Borchelt DR et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995; 14: 1105-16.
29. Kong J, Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci 1998; 18: 3241-50.
30. Vielhaber S, Kunz D, Winkler K et al. Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain 2000; 123: 1339-48.
31. Vielhaber S, Winkler K, Kirches E et al. Visualization of defective mitochondrial function in skeletal muscle fibers of patients with sporadic amyotrophic lateral sclerosis. J Neurol Sci 1999; 169: 133-9.
32. Wiedemann FR, Winkler K, Kuznetsov AV et al. Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J Neurol Sci 1998; 156: 65-72.
33. Sasaki S, Iwata M. Dendritic synapses of anterior horn neurons in amyotrophic lateral sclerosis: an ultrastructural study. Acta Neuropathol (Berl) 1996; 91: 278-83.
34. Sasaki S, Komori T, Iwata M. Excitatory amino acid transporter 1 and 2 immunoreactivity in the spinal cord in amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 2000; 100: 138-44.
35. Ghiseli A, Laurenti O, DeMattia G et al. Salicylate hydroxylation as an early marker of in vivo oxidative stress in diabetic patients. Free Rad Biol Med 1992; 13: 621-626.
36. Thome J, Zhang J, Davids E et al. Evidence for increased oxidative stress in alcohol-dependent patients provided by quantification of in vivo salicylate hydroxylation products. Alcohol Clin Exp Res 1997; 21: 82-85.
37. Kaur H, Edmonds SE, Blake DR, Halliwell C. Hydroxyl radical generation by rheumatoid blood and knee joint synovial fluid. Ann Rheum Dis 1996; 55: 915-920.
38. Kaur H, Whiteman M, Halliwell B. Peroxynitrite-dependent aromatic hydroxylation and nitration of salicylate and phenylalanine. Is hydroxyl radical involved?. Free Rad Res 1997; 26: 71-82.
39. Narayan M, Berliner LJ, Merola AJ et al. Biological reactions of peroxynitrite: evidence for an alternative pathway of salicylate hydroxylation. Free Rad Res 1997; 27: 63-72.
40. Beckman JS. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 1996; 9: 836-844.
41. Beckman JS, Beckman TW, Chen J et al. Apparent free radical production by peroxynitrite: implications for endothelial injury form nitric oxide and superoxide. Proc Nat Acad Sci USA 1990; 170: 1620-1624.